Wedbush maintains Nuvation Bio price target at $11
Wedbush maintained a $11.00/share price target for Nuvation Bio (NUVB), per Benzinga’s ratings action recap.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.